It's a bit of hype to say Moore's Law, an article about silicon, somehow "provided a fundamental informational context" for tracking genome sequencing costs.
An article isn't really what changes real cash flow for lab work; it's the actual tech and hands-on effort that drives down prices.
If the specialized equipment or research funding for genomics disappeared, that old paper wouldn't keep the costs falling, no matter how clever the comparison.
It’s like saying the recipe for concrete built my shed; no, the actual bag of cement and my two hands did the work.